Pharmaron Beijing Co., Ltd. (300759.SZ) disclosed that on January 28, 2026, it issued a total of 81,643 A shares and 565,698 A shares under its 2021 and 2022 Restricted A Share Incentive Schemes, respectively. The issue prices were reported as RMB 30.39 per share and RMB 25.15 per share. According to the announcement, these issuance numbers are subject to final confirmation from the securities depository house in China.
Following the issuances, the total number of issued shares (excluding treasury shares) increased from 1,476,658,400 to 1,477,305,741. All relevant approvals related to these issuances were duly passed at earlier shareholders’ and class meetings, with details found in the company’s prior circulars and overseas regulatory announcements. The company indicated that it may revise the final issuance figures if an update is required.
Comments